Invention Grant
- Patent Title: Isatin derivatives
-
Application No.: US16932787Application Date: 2020-07-19
-
Publication No.: US11945809B2Publication Date: 2024-04-02
- Inventor: Ahmed Bari , Saeed Ali Syed , Mohammad A. Altamimi
- Applicant: KING SAUD UNIVERSITY
- Applicant Address: SA Riyadh
- Assignee: KING SAUD UNIVERSITY
- Current Assignee: KING SAUD UNIVERSITY
- Current Assignee Address: SA Riyadh
- Agency: Nath, Goldberg & Meyer
- Agent Richard C. Litman
- Main IPC: C07D409/12
- IPC: C07D409/12 ; A61P35/00
Abstract:
A method of treating cancer can include administering one or more of the isatin derivatives to a patient in need thereof. In an embodiment, the cancer is selected from the group consisting of breast cancer, non-small cell lung cancer, renal cancer and melanoma. The isatin derivative is selected from the group consisting of:
Public/Granted literature
- US20230357213A1 ISATIN DERIVATIVES Public/Granted day:2023-11-09
Information query
